Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Open accessAbstract
This study aimed to determine if there is an association between dysbiosis and nonalcoholic fatty liver disease (NAFLD) independent of obesity and insulin resistance (IR). This is a prospective cross-sectional study assessing the intestinal microbiome (IM) of 39 adults with biopsy-proven NAFLD (15 simple steatosis [SS]; 24 nonalcoholic steatohepatitis [NASH]) and 28 healthy controls (HC). IM composition (llumina MiSeq Platform) in NAFLD patients compared to HC were identified by two statistical methods (Metastats, Wilcoxon). Selected taxa was validated using quantitative PCR (qPCR). Metabolites in feces and serum were also analyzed. In NAFLD, 8 operational taxonomic units, 6 genera, 6 families and 2 phyla (Bacteroidetes, Firmicutes) were less abundant and; 1 genus ( Lactobacillus ) and 1 family (Lactobacillaceae) were more abundant compared to HC. Lower abundance in both NASH and SS patients compared to HC were confirmed by qPCR for Ruminococcus, Faecalibacterium prausnitzii and Coprococcus . No difference was found between NASH and SS. This lower abundance in NAFLD (NASH+SS) was independent of BMI and IR. NAFLD patients had higher concentrations of fecal propionate and isobutyric acid and serum 2-hydroxybutyrate and L-lactic acid. These findings suggest a potential role for a specific IM community and functional profile in the pathogenesis of NAFLD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Diseases linked to dyslipidemia, such as non-alcoholic liver disease and atherosclerosis, are associated with changes in gut microbiota profile.
“Furthermore, diseases linked to dyslipidemia, such as non-alcoholic liver disease and atherosclerosis, are associated with changes in gut microbiota profile.”
From Dietary lipids, gut microbiota and lipid metabolism (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · see citing works
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055 · see citing works
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,769 · see citing works
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 20,966 · see citing works
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,617 · see citing works
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839 · see citing works
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815 · see citing works
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · see citing works
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320 · see citing works
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · see citing works
Microbiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · see citing works
Differential abundance analysis for microbial marker-gene surveys
Paulson, J. N., Stine, O. C., Bravo, H. C., & Pop, M. (2013) · Nature Methods · doi:10.1038/nmeth.2658 · Cited by 2,437 · see citing works
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,413 · see citing works
PANDAseq: paired-end assembler for Illumina sequences
Masella, A. P., Bartram, A. K., Truszkowski, J. M., Brown, D. G., & Neufeld, J. D. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-31 · Cited by 2,132 · see citing works
Regulation of short-chain fatty acid production
Macfarlane, S., & Macfarlane, G. T. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2002207 · Cited by 1,939 · see citing works
Psychogios, N., Hau, D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., Sinelnikov, I. V., Krishnamurthy, R., Eisner, R., Gautam, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016957 · Cited by 1,718 · see citing works
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · see citing works
Bullard, J. H., Purdom, E., Hansen, K. D., & Dudoit, S. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-94 · Cited by 1,680 · see citing works
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,581 · see citing works
Odamaki, T., Kato, K., Sugahara, H., Hashikura, N., Takahashi, S., Xiao, J.-Z., Abe, F., & Osawa, R. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0708-5 · Cited by 1,521 · see citing works
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · see citing works
Jumpertz, R., Le, D. S., Turnbaugh, P. J., Trinidad, C., Bogardus, C., Gordon, J. I., & Krakoff, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.010132 · Cited by 1,232 · see citing works
Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects
Radilla-Vázquez, R. B., Parra‐Rojas, I., Martínez-Hernández, N. E., Márquez‐Sandoval, F., Illades‐Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,200 · see citing works
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y. H., Younossi, Y., Mir, H., & Srishord, M. K. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,072 · see citing works
The role of the gut microbiota in NAFLD
Leung, C., Rivera, L., Furness, J. B., & Angus, P. W. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.85 · Cited by 1,020 · see citing works
Intestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749 · see citing works
Self-citationDel Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., Furlanello, C., Zandonà, A., Paci, P., Capuani, G., et al. (2017) · Hepatology · doi:10.1002/hep.28572 · Cited by 696 · see citing works
Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672 · see citing works
Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y. C., Li, J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep08096 · Cited by 650 · see citing works
Spencer, M. D., Hamp, T. J., Reid, R. W., Fischer, L. M., Zeisel, S. H., & Fodor, A. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.049 · Cited by 593 · see citing works
Species divergence and the measurement of microbial diversity
Lozupone, C., & Knight, R. D. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00111.x · Cited by 546 · see citing works
World Gastroenterology Organisation Global Guidelines
LaBrecque, D. R., Abbas, Z., Anania, F. A., Ferenci, P., Khan, A. G., Goh, K., Hamid, S. S., Va, I., Lizarzábal, M., Peñaranda, M. M., et al. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000116 · Cited by 520 · see citing works
From the metabolic syndrome to NAFLD or vice versa?
Vanni, E., Bugianesi, E., Kotronen, A., Minicis, S. D., Yki‐Järvinen, H., & Svegliati‐Baroni, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.016 · Cited by 494 · see citing works
Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E., & Liang, J. T. (2010) · Hepatology · doi:10.1002/hep.23759 · Cited by 473 · see citing works
(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease
Buford, T. W. (2017) · Microbiome · doi:10.1186/s40168-017-0296-0 · Cited by 409 · see citing works
Ferrannini, E., Natali, A., Camastra, S., Nannipieri, M., Mari, A., Adam, K., Milburn, M. V., Kastenmüller, G., Adamski, J., Tuomilehto, J., et al. (2012) · Diabetes · doi:10.2337/db12-0707 · Cited by 350 · see citing works
Le Gall, G., Noor, S. O., Ridgway, K., Scovell, L., Jamieson, C., Johnson, I. T., Colquhoun, I. J., Kemsley, E. K., & Narbad, A. (2011) · Journal of Proteome Research · doi:10.1021/pr2003598 · Cited by 348 · see citing works
Wong, V. W., Tse, C., Lam, T. T., Wong, G. L., Chim, A. M., Chu, C. W., Yeung, D. K., Law, P. T. W., Kwan, H. S., Yu, J. Q., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062885 · Cited by 342 · see citing works
Arendt, B. M., Comelli, E. M., David, W. L., Lou, W. Y. W., Teterina, A. A., Kim, T., Fung, S. K., Wong, D., McGilvray, I. D., Fischer, S. E., et al. (2015) · Hepatology · doi:10.1002/hep.27695 · Cited by 335 · see citing works
Self-citationMicrobiome profiling by Illumina sequencing of combinatorial sequence-tagged PCR products
Gloor, G. B., Hummelen, R., Macklaim, J. M., Dickson, R. J., Fernandes, A. D., MacPhee, R., & Reid, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015406 · Cited by 330 · see citing works
Microbiota-liver axis in hepatic disease
Chassaing, B., Etienne‐Mesmin, L., & Gewirtz, A. T. (2013) · Hepatology · doi:10.1002/hep.26494 · Cited by 329 · see citing works
Utilisation of Mucin Glycans by the Human Gut Symbiont Ruminococcus gnavus Is Strain-Dependent
Crost, E. H., Tailford, L. E., Gall, G. L., Fons, M., Henrissat, B., & Juge, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076341 · Cited by 315 · see citing works
Marchesini, G., Petta, S., & Grave, R. D. (2015) · Hepatology · doi:10.1002/hep.28392 · Cited by 291 · see citing works
Shaw, K. A., Bertha, M., Hofmekler, T., Chopra, P., Vatanen, T., Srivatsa, A., Prince, J., Kumar, A., Sauer, C. G., Zwick, M. E., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0331-y · Cited by 278 · see citing works
The butyrate story: old wine in new bottles?
Scheppach, W. M., & Weiler, F. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200409000-00009 · Cited by 246 · see citing works
The gut microbial community in metabolic syndrome patients is modified by diet
Haro, C., García‐Carpintero, S., Alcala-Diaz, J. F., Gómez-Delgado, F., Delgado‐Lista, J., Pérez‐Martínez, P., Rangel-Zúñiga, O. A., Quintana‐Navarro, G. M., Landa, B. B., Clemente, J. C., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.011 · Cited by 216 · see citing works
Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease
Wieland, A. C., Frank, D. N., Harnke, B., & Bambha, K. M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13376 · Cited by 209 · see citing works
Su, D., Nie, Y., Zhu, A., Chen, Z., Wu, P., Zhang, L., Luo, M., Sun, Q., Cai, L., Lai, Y.-C., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00498 · Cited by 197 · see citing works
Fecal Acetate Is Inversely Related to Acetate Absorption from the Human Rectum and Distal Colon
Vogt, J. A., & Wolever, T. M. S. (2003) · Journal of Nutrition · doi:10.1093/jn/133.10.3145 · Cited by 151 · see citing works
Insulin resistance in development and progression of nonalcoholic fatty liver disease
Alam, S., Mustafa, G., Alam, M., & Ahmad, N. (2016) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v7.i2.211 · Cited by 110 · see citing works
Effect of high fat-diet and obesity on gastrointestinal motility.
Mushref, M. A., & Srinivasan, S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2012.11.01 · Cited by 105 · see citing works
Compositional dynamics of the human intestinal microbiota with aging: Implications for health
Lakshminarayanan, B., Stanton, C., O’Toole, P. W., & Ross, R. P. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0549-6 · Cited by 91 · see citing works
Silva, H. E. D., Arendt, B. M., Noureldin, S. A., Therapondos, G., Guindi, M. M., & Allard, J. P. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.01.009 · Cited by 86 · see citing works
Self-citationSartor, R. B. (2011) · Mucosal Immunology · doi:10.1038/mi.2010.87 · Cited by 75 · see citing works
Hynönen, U., Rasinkangas, P., Satokari, R. M., Paulin, L. G., de Vos, W. M., Pietilä, T. E., Kant, R., & Palva, A. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.03.001 · Cited by 35 · see citing works
Remembering Rhodes’ Detractors
Hughes, H. A. (2016) · The Round Table · doi:10.1080/00358533.2016.1154666 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [57]Doelle, H. W. Bacterial Metabolism. Second edn, 416–419 (Academic Press, Inc., 1975).
Cited by
Sorted by citations
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works
Gut microbial metabolites in obesity, NAFLD and T2DM
Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0156-z · Cited by 1,493 · see citing works
Dietary lipids, gut microbiota and lipid metabolism
Schoeler, M., & Caesar, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09512-0 · Cited by 1,163 · see citing works
Short chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103 · see citing works
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron‐Wisnewsky, J., Vigliotti, C., Witjes, J. J., Le, P. T., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,085 · see citing works
Targher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 848 · see citing works
Role and Mechanism of Gut Microbiota in Human Disease
Chen, Y., Zhou, J., & Wang, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.625913 · Cited by 643 · see citing works
The role of the gut microbiome and its metabolites in metabolic diseases
Wu, J., Wang, K., Wang, X., Pang, Y., & Jiang, C. (2020) · Protein & Cell · doi:10.1007/s13238-020-00814-7 · Cited by 584 · see citing works
The links between gut microbiota and obesity and obesity related diseases
Geng, J., Ni, Q., Sun, W., Li, L., & Feng, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112678 · Cited by 410 · see citing works
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Oh, T. G., Kim, S. M., Caussy, C., Fu, T., Guo, J. P., Bassirian, S., Singh, S., Madamba, E. V., Bettencourt, R., Richards, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.005 · Cited by 337 · see citing works
Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
Yaskolka Meir, A., Rinott, E., Tsaban, G., Zelicha, H., Kaplan, A., Rosen, P., Shelef, I., Youngster, I., Shalev, A., Blüher, M., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323106 · Cited by 287 · see citing works
Григорьева, И. Н. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm11010013 · Cited by 288 · see citing works
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Aron‐Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M., & Clément, K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.049 · Cited by 245 · see citing works
Scorletti, E., Afolabi, P. R., Miles, E. A., Smith, D. E., Almehmadi, A., Alshathry, A., Childs, C. E., Del Fabbro, S., Bilson, J., Moyses, H. E., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.031 · Cited by 237 · see citing works
The critical role of Faecalibacterium prausnitzii in human health: An overview
Leylabadlo, H. E., Ghotaslou, R., Feizabadi, M. M., Farajnia, S., Moaddab, S. Y., Ganbarov, K., Khodadadi, E., Tanomand, A., Sheykhsaran, E., Yousefi, B., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104344 · Cited by 239 · see citing works
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Portincasa, P., Bonfrate, L., Khalil, M., Angelis, M. D., Calabrese, F. M., D’Amato, M., Wang, D. Q. ‐., & Ciaula, A. D. (2021) · Biomedicines · doi:10.3390/biomedicines10010083 · Cited by 212 · see citing works
Zhang, S., Zhao, J., Xie, F., He, H., Johnston, L. J., Dai, X., Wu, C., & Ma, X. (2021) · Obesity Reviews · doi:10.1111/obr.13316 · Cited by 215 · see citing works
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Sookoian, S. C., Salatino, A., Castaño, G. O., Landa, M. S., Fijalkowky, C., Garaycoechea, M. E., & Pirola, C. J. (2020) · Gut · doi:10.1136/gutjnl-2019-318811 · Cited by 204 · see citing works
Velázquez, K. T., Enos, R. T., Bader, J. E., Sougiannis, A. T., Carson, M. S., Chatzistamou, I., Carson, J. A., Nagarkatti, P. S., Nagarkatti, M., & Murphy, E. A. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i8.619 · Cited by 188 · see citing works
Hrncir, T., Hrncirova, L., Kverka, M., Hromádka, R., Machova, V., Trckova, E., Kostovcikova, K., Králíčková, P., Krejsek, J., & Tlaskalová‐Hogenová, H. (2021) · Microorganisms · doi:10.3390/microorganisms9050957 · Cited by 179 · see citing works
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
Schwenger, K. J. P., Clermont‐Dejean, N. M., & Allard, J. P. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.04.004 · Cited by 171 · see citing works
Self-citationSharpton, S. R., Ajmera, V. H., & Loomba, R. S. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.065 · Cited by 170 · see citing works
Fang, W., Xue, H., Chen, X., Chen, K., & Ling, W. (2019) · Journal of Nutrition · doi:10.1093/jn/nxy324 · Cited by 164 · see citing works
Burra, P., Bizzaro, D., Gonta, A., Shalaby, S., Gambato, M., Morelli, M. C., Trapani, S., Floreani, A., Marra, F., Brunetto, M. R., et al. (2021) · Liver International · doi:10.1111/liv.14943 · Cited by 159 · see citing works
Risk assessment with gut microbiome and metabolite markers in NAFLD development
Leung, H., Long, X., Ni, Y., Qian, L., Nychas, E., Siliceo, S. L., Pohl, D., Hanhineva, K., Liu, Y., Xu, A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk0855 · Cited by 152 · see citing works
Role of gut microbiota in liver disease
Albhaisi, S. A. M., Bajaj, J. S., & Sanyal, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00118.2019 · Cited by 153 · see citing works
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui, H. (2019) · Diseases · doi:10.3390/diseases7040058 · Cited by 151 · see citing works
Delzenne, N. M., Knudsen, C., Beaumont, M., Rodriguez, J., Neyrinck, A. M., & Bindels, L. B. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002756 · Cited by 140 · see citing works
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Tanaka, N., Kimura, T., Fujimori, N., Nagaya, T., Komatsu, M., & Tanaka, E. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i2.163 · Cited by 139 · see citing works
Boland, M. L., Oró, D., Tølbøl, K. S., Thrane, S. T., Nielsen, J. C., Cohen, T. S., Tabor, D. E., Fernandes, F., Tovchigrechko, A., Veidal, S. S., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4904 · Cited by 129 · see citing works
Li, F., Ye, J., Shao, C., & Zhong, B. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01440-w · Cited by 118 · see citing works
Choi, B. S.-Y., Daniel, N., Houde, V. P., Ouellette, A., Marcotte, B., Varin, T. V., Vors, C., Feutry, P., Ilkayeva, O., Ståhlman, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23782-w · Cited by 113 · see citing works
Drożdż, K., Nabrdalik, K., Hajzler, W., Kwiendacz, H., Gumprecht, J., & Lip, G. Y. H. (2021) · Nutrients · doi:10.3390/nu14010103 · Cited by 112 · see citing works
The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
Jasirwan, C. O. M., Lesmana, C. R. A., Hasan, I., Sulaiman, A. S., & Gani, R. A. (2019) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.18-032 · Cited by 112 · see citing works
Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
Quesada‐Vázquez, S., Aragonès, G., Bas-Prior, J. M. D., & Escoté, X. (2020) · Cells · doi:10.3390/cells9010176 · Cited by 106 · see citing works
Microbial Metabolites: Critical Regulators in NAFLD
Dai, X., Hou, H., Zhang, W., Liu, T., Li, Y., Wang, S., Wang, B., & Cao, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.567654 · Cited by 102 · see citing works
Hu, W., Gao, W., Liu, Z., Fang, Z., Wang, H., Zhao, J., Zhang, H., Lu, W., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14142945 · Cited by 98 · see citing works
The pathophysiology of MASLD: an immunometabolic perspective
Schwärzler, J., Grabherr, F., Grander, C., Adolph, T. E., & Tilg, H. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2294046 · Cited by 102 · see citing works
Gut Dysfunction and Non-alcoholic Fatty Liver Disease
Grabherr, F., Grander, C., Effenberger, M., Adolph, T. E., & Tilg, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00611 · Cited by 97 · see citing works
Kanda, T., Goto, T., Hirotsu, Y., Masuzaki, R., Moriyama, M., & Omata, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041525 · Cited by 95 · see citing works
Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
Long, Q., Luo, F., Li, B., Li, Z., Guo, Z., Chen, Z., Wu, W., & Hu, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000310 · Cited by 94 · see citing works
Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves' Disease
Jiang, W., Yu, X., Kosik, R. O., Song, Y., Qiao, T., Tong, J., Liu, S., Fan, S., Luo, Q., Chai, L., et al. (2020) · Thyroid · doi:10.1089/thy.2020.0193 · Cited by 90 · see citing works
Alferink, L. J. M., Radjabzadeh, D., Erler, N. S., Vojinović, D., Medina‐Gómez, C., Uitterlinden, A. G., de Knegt, R. J., Amin, N., Ikram, M. A., Janssen, H. L. A., et al. (2020) · Hepatology · doi:10.1002/hep.31417 · Cited by 87 · see citing works
Liang, D., Zhang, L., Chen, H., Zhang, H., Hu, H., & Dai, X. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.209 · Cited by 86 · see citing works
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH).
Duarte, S. M., Stefano, J., & Oliveira, C. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.04.006 · Cited by 70 · see citing works
Xie, Y., Zou, X., Han, J., Zhang, Z., Feng, Z., Ouyang, Q., Hua, S., Liu, Z., Li, C., Cai, Y., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114081 · Cited by 80 · see citing works
NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations
Niederseer, D., Wernly, B., Aigner, E. S., Stickel, F., & Datz, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030467 · Cited by 82 · see citing works
Hodges, J. K., Sasaki, G. Y., & Bruno, R. S. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108478 · Cited by 76 · see citing works
Intestinal virome and therapeutic potential of bacteriophages in liver disease
Hsu, C. L., Duan, Y., Fouts, D. E., & Schnabl, B. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.003 · Cited by 77 · see citing works
Sun, R., Xu, D., Wei, Q., Zhang, B., Aa, J., Wang, G., & Xie, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109721 · Cited by 75 · see citing works
Hernández-Baixauli, J., Quesada‐Vázquez, S., Mariné-Casadó, R., Cardoso, K. G., Caimari, A., Bas-Prior, J. M. D., Escoté, X., & Baselga‐Escudero, L. (2020) · Nutrients · doi:10.3390/nu12030806 · Cited by 73 · see citing works
Su, X. B., Chen, S., Liu, J., Feng, Y., Han, E., Hao, X., Liao, M., Cai, J., Zhang, S., Niu, J., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13646 · Cited by 74 · see citing works
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Portincasa, P., Khalil, M., Graziani, A., Frühbeck, G., Baffy, G., Garruti, G., Ciaula, A. D., & Bonfrate, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.002 · Cited by 74 · see citing works
Dongiovanni, P., Paolini, E., Corsini, A., Sirtori, C. R., & Ruscica, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13519 · Cited by 70 · see citing works
Qian, M., Liu, J., Zhao, D., Cai, P., Pan, C., Jia, W., Gao, Y., Zhang, Y., Zhang, N., Zhang, Y., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.014 · Cited by 69 · see citing works
Jian, C., Luukkonen, P. K., Sädevirta, S., Yki‐Järvinen, H., & Salonen, A. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.008 · Cited by 67 · see citing works
Ahmed, B. A., Ong, F. J., Barra, N. G., Blondin, D. P., Gunn, E., Oreskovich, S. M., Szamosi, J. C., Syed, S. A., Hutchings, E. K., Konyer, N. B., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100397 · Cited by 67 · see citing works
The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression
Chen, D., Le, T. H., Shahidipour, H., Read, S. A., & Ahlenstiel, G. (2019) · Cells · doi:10.3390/cells8111324 · Cited by 67 · see citing works
Nguyen, H. T., Gu, M., Werlinger, P., Cho, J.-H., Cheng, J., & Suh, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113436 · Cited by 64 · see citing works
Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
Wang, C., Zhu, C., Shao, L., Ye, J., Shen, Y., & Ren, Y. (2019) · Mediators of Inflammation · doi:10.1155/2019/7659509 · Cited by 64 · see citing works
Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases
Kim, H., Joo, E., Cheong, H. S., Kim, Y., Kim, H., Shin, H. C., Chang, Y., & Ryu, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081089 · Cited by 60 · see citing works
Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis
Thavamani, A., Salem, I., Sferra, T. J., & Sankararaman, S. (2021) · Metabolites · doi:10.3390/metabo11020123 · Cited by 59 · see citing works
Soppert, J., Brandt, E. F., Heussen, N. M., Barzakova, E., Blank, L. M., Kuepfer, L., Hornef, M. W., Trebicka, J., Jankowski, J., Berres, M., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.11.030 · Cited by 56 · see citing works
Shin, J., Lee, Y., Song, E., Lee, D., Jang, S.-Y., Byeon, H. R., Hong, M.-G., Lee, S., Kim, H., Seo, J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1123547 · Cited by 56 · see citing works
Yarahmadi, A., Afkhami, H., Javadi, A., & Kashfi, M. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01561-z · Cited by 59 · see citing works
Jadhav, K. S., & Cohen, T. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.592157 · Cited by 53 · see citing works
Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome
Rong, J., Zhang, Z., Peng, X., Li, P., Zhao, T., & Zhong, Y. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.100394 · Cited by 54 · see citing works
Kuraji, R., Shiba, T., Dong, T. S., Numabe, Y., & Kapila, Y. L. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i6.967 · Cited by 51 · see citing works
High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD
Lang, S., Martin, A., Farowski, F., Wisplinghoff, H., Vehreschild, M. J. G. T., Liu, J., Krawczyk, M. J., Nowag, A., Kretzschmar, A., Herweg, J., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1509 · Cited by 49 · see citing works
Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
Demir, M., Lang, S., Martin, A., Farowski, F., Wisplinghoff, H., Vehreschild, M. J. G. T., Krawczyk, M. J., Nowag, A., Scholz, C. J., Kretzschmar, A., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15071 · Cited by 49 · see citing works
He, L., Yao, D.-H., Wang, L., Zhang, L., & Bai, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.761836 · Cited by 48 · see citing works
Zhao, N., Yang, Y., Chen, C., Jing, T., Hu, Y., Xu, H., Wang, S., He, Y., Liu, E., & Cui, J. (2022) · Food & Function · doi:10.1039/d2fo02942a · Cited by 48 · see citing works
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Zhou, J., Tripathi, M., Sinha, R. A., Singh, B. K., & Yen, P. M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.134 · Cited by 47 · see citing works
Hui, D., Liu, L., Azami, N. L. B., Song, J., Huang, Y., Xu, W., Wu, C., Xie, D., Jiang, Y., Bian, Y., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1107071 · Cited by 47 · see citing works
Gudan, A., Kozłowska‐Petriczko, K., Wunsch, E., Bodnarczuk, T., & Stachowska, E. (2023) · Nutrients · doi:10.3390/nu15061323 · Cited by 48 · see citing works
Yang, C., Wu, J., Yang, L., Hu, Q., Li, L., Yang, Y., Jing Hua, H. U., Pan, D., & Zhao, Q. (2024) · Scientific Reports · doi:10.1038/s41598-024-72909-8 · Cited by 47 · see citing works
Magueresse‐Battistoni, B. L. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.129212 · Cited by 47 · see citing works
Yadav, J., Liang, T., Qin, T., Nathan, N., Schwenger, K. J. P., Pickel, L., Xie, L., Lei, H., Winer, D. A., Maughan, H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101051 · Cited by 47 · see citing works
Self-citationIwaki, M., Kessoku, T., Ozaki, A., Kasai, Y., Kobayashi, T., Nogami, A., Honda, Y., Ogawa, Y., Imajo, K., Yoneda, M., et al. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15487 · Cited by 44 · see citing works
The role of microbiota in nonalcoholic fatty liver disease
Ciaula, A. D., Bonfrate, L., & Portincasa, P. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13768 · Cited by 43 · see citing works
Amiri, P., Arefhosseini, S., Bakhshimoghaddam, F., Gurvan, H. J., & Hosseini, S. A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1037696 · Cited by 42 · see citing works
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Iruzubieta, P., Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051369 · Cited by 44 · see citing works
Sun, C., Xiong, X., Liu, M., Qi, L., Zhao, Q., Wei, G., Shi, J., & Li, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117156 · Cited by 41 · see citing works
Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
Chiriac, S. A., Stanciu, C., Gîrleanu, I., Cojocariu, C., Sfarti, C. V., Sîngeap, A.-M., Cuciureanu, T., Huiban, L., Muzica, C. M., Zenovia, S., et al. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/6696857 · Cited by 41 · see citing works
Cornejo-Pareja, I. M., Amiar, M. R., Ocaña-Wilhelmi, L., Soler-Humanes, R., Arranz‐Salas, I., Garrido‐Sánchez, L., Gutiérrez‐Repiso, C., & Tinahones, F. J. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-023-02075-7 · Cited by 40 · see citing works
Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
Schwenger, K. J. P., Bolzon, C. M., Li, C., & Allard, J. P. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1844-5 · Cited by 40 · see citing works
Self-citationGómez‐Zorita, S., Aguirre, L., Milton‐Laskibar, I., Fernández‐Quintela, A., Trepiana, J., Kajarabille, N., Mosqueda-Solís, A., González, M. A., & Portillo, M. P. (2019) · Nutrients · doi:10.3390/nu11092156 · Cited by 40 · see citing works
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
Scarpellini, E., Scarcella, M., Tack, J. F., Scarlata, G. G. M., Zanetti, M., & Abenavoli, L. (2024) · Antioxidants · doi:10.3390/antiox13111386 · Cited by 39 · see citing works
Microbiota and nonalcoholic fatty liver disease
Knudsen, C., Neyrinck, A. M., Lanthier, N., & Delzenne, N. M. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000584 · Cited by 39 · see citing works
Non-alcoholic fatty liver disease: Not time for an obituary just yet!
Singh, S. P., Anirvan, P., Reddy, K. R., Conjeevaram, H. S., Marchesini, G., Rinella, M. E., Madan, K., Petroni, M. L., Al‐Mahtab, M., Caldwell, S. H., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.10.015 · Cited by 39 · see citing works
Exploiting the interactions between plant proteins and gut microbiota to promote intestinal health
Jia, J., Dell’Olio, A., Izquierdo-Sandoval, D., Capuano, E., Liu, X., Duan, X., & Rubert, J. (2024) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2024.104749 · Cited by 41 · see citing works
Kriss, M. S., Verna, E. C., Rosen, H. R., & Lozupone, C. (2018) · Transplantation · doi:10.1097/tp.0000000000002568 · Cited by 37 · see citing works
Rodriguez, D. M., Benninghoff, A. D., Aardema, N. D. J., Phatak, S., & Hintze, K. J. (2019) · Nutrients · doi:10.3390/nu11071630 · Cited by 36 · see citing works
Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
Sharpton, S. R., Yong, G. J. M., Terrault, N. A., & Lynch, S. V. (2018) · Hepatology Communications · doi:10.1002/hep4.1284 · Cited by 35 · see citing works
Pettinelli, P., Arendt, B. M., Schwenger, K. J. P., Sivaraj, S., Bhat, M., Comelli, E. M., Lou, W. Y. W., & Allard, J. P. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000466 · Cited by 35 · see citing works
Self-citationLang, S., Farowski, F., Martin, A., Wisplinghoff, H., Vehreschild, M. J. G. T., Krawczyk, M. J., Nowag, A., Kretzschmar, A., Scholz, C. J., Kasper, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66241-0 · Cited by 35 · see citing works
Yan, X., Li, L., Liu, P., Xu, J., Wang, Z., Ding, L., & Yang, L. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.114620 · Cited by 34 · see citing works
Bacteroides and NAFLD: pathophysiology and therapy
Zhang, J., Zhou, J., He, Z., & Li, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1288856 · Cited by 35 · see citing works
Tsai, H.-J., Hung, W., Hung, W., Lee, Y.-J., Chen, Y.-C., Lee, C., Tsai, Y., & Dai, C. (2023) · Nutrients · doi:10.3390/nu15071712 · Cited by 33 · see citing works
Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies
López‐Moreno, A., Acuña, I., Torres-Sánchez, A., Ruiz-Moreno, Á., Cerk, K., Rivas, A., Suárez, A., Monteoliva‐Sánchez, M., & Aguilera, J. (2021) · Nutrients · doi:10.3390/nu13051617 · Cited by 32 · see citing works
- Authors
- Da Silva, H. E., Teterina, A., Comelli, E. M., Taibi, A., Arendt, B. M., Fischer, S. E., Lou, W., & Allard, J. P.
- Affiliations
- University Health Network (CA)
- University of Toronto (CA)
- Corresponding author
- Allard, Johane P.
- ORCID
- Venue
- Scientific Reports
- Published
- 2018-01-23
- Volume
- 8
- Issue
- 1
- Pages
- 1466-1466
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5780381
- OpenAlex
- W2803148575
- Cited by
- 283
- References
- 59
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 31 · 2023: 34 · 2022: 35 · 2021: 60 · 2020: 34 · 2019: 27 · 2018: 10
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American College of Gastroenterology
- University of Alberta
- University of Toronto
- Canadian Institutes of Health Research (86922_1, 89705_1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut microbiota, dysbiosis, obesity, insulin resistance, Bacteroidetes, Firmicutes, Faecalibacterium prausnitzii, Ruminococcus, Coprococcus, Lactobacillus, short-chain fatty acids, propionate, isobutyric acid, 2-hydroxybutyrate, L-lactic acid, gut microbiota metabolites
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Cross-Sectional Studies, Feces, Female, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Prospective Studies, Body Mass Index, Young Adult, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
